Wanda Phipatanakul
Director, Clinical Research Center, Asthma, Allergy, Dermatology, Rheumatology, and Immunology · Beth Israel Deaconess Medical Center
Credentials: · · · ·
History
- Present
Clinical Research Center · Beth Israel Deaconess Medical Center
1997–1998- 1994–1997
Internal Medicine
Research
Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations
American Journal of Respiratory and Critical Care Medicine · 2017 · 362 citations
Review · Environmental Health Perspectives · 2015 · Last of 5 authors · 278 citations
Allergic Endotypes and Phenotypes of Asthma
The Journal of Allergy and Clinical Immunology In Practice · 2020 · Last of 4 authors · Corresponding · 260 citations
93 papers · 8 as a fellow
78 papers
59 papers
55 papers
- EI
49 papers
42 papers
- SB
39 papers
38 papers
Grants
- 2025–2030
Radon Asthma Intervention Trial (ROME)
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.5M · Boston Children's Hospital
- 2024–2029
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $6.8M · Boston Children's Hospital
- 2021–2028
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.8M · Boston Children's Hospital
- 2019–2027
Effect of IL-4RαR576 Variant on Response to Dupilumab in Children with Asthma
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $8.4M · Boston Children's Hospital
Clinical trials
- 2027–2029
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
Principal investigator · Withdrawn · Phase 2
Boston Children's Hospital
- 2026–2030
Radon Asthma Intervention Trial
Principal investigator · Not yet recruiting
Boston Children's Hospital
- 2021–2027
Investigating Dupilumab's Effect in Asthma by Genotype
Principal investigator · Active not recruiting · Phase 4
Boston Children's Hospital
- 2020–2027
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
Principal investigator · Recruiting
Boston Children's Hospital